GCV Symposium
Skip Content

1 December 2017

Bhaman moves on to Sofinnova

Maina Bhaman has joined Sofinnova Partners after serving as director of healthcare investment at Touchstone Innovations for over a decade.

Author: Thierry Heles, editor

Maina Bhaman (pictured) left Touchstone Innovations, the commercialisation firm spun out of Imperial College London, yesterday to join life sciences-focused venture capital firm Sofinnova Partners.

Bhaman has been appointed partner at Sofinnova. She previously held the position of director of healthcare investment at Touchstone since 2006.

During her time with Touchstone, she co-led a wide array of investments and took board seats at a range of UK-based biotechnology developers, such as Puridify, which was sold to GE this week.

Bhaman says: “I am thrilled to join such an experienced team as Sofinnova Partners. We have worked together on a number of co-investments, and clearly share a common approach and vision.

“I am looking forward to continue to pursue my passion of backing entrepreneurs developing paradigm-shifting technologies that may significantly improve patients’ life.”

Antoine Papiernik, managing partner and chairman of Sofinnova, said: “We are extremely happy to welcome Maina as a Partner in our team. Her expertise and track record are a perfect match with our team and strategy.

“This recruitment also furthers our international reach and will positively contribute to Sofinnova Partners’ growth.”

– Image courtesy of Touchstone Innovations

Copyright Mawsonia Limited 2010. Please don´t cut articles from www.globaluniversityventuring.com or the PDF and redistribute by email or post to the web without written permission.

  • Linkedin
  • Mail
  • Rssfeed